Elevated liver function tests in a patient on palbociclib and fulvestrantDecember 6, 2018Breast Cancer
Symptom burdens related to chemotherapy-induced anemia in stage IV cancerDecember 5, 2018Patient & Survivor CareBreast CancerLung CancerLymphoma & Plasma Cell Disorders
Neratinib extends adjuvant treatment of patients with HER2-positive breast cancerAugust 26, 2018Breast Cancer
Meeting the potential of immunotherapy: new targets provide rational combinationsAugust 15, 2018GastroenterologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersImmunotherapyLymphoma & Plasma Cell DisordersMelanoma
ASCO 2018: Less is more as ‘tailoring’ takes on new meaningJune 21, 2018Breast CancerLung CancerGenitourinary Cancer
The long-term effects of posttreatment exercise on pain in young women with breast cancerJune 21, 2018Breast CancerPatient & Survivor Care
2017 notches up some landmark approvalsMay 14, 2018Breast CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Integrating survivorship care planning in radiation oncology workflowApril 29, 2018Breast CancerPatient & Survivor CareOncology
Analgesic management in radiation oncology for painful bone metastasesApril 8, 2018Patient & Survivor CareBreast CancerGenitourinary CancerLung Cancer
Measurement of physical activity and sedentary behavior in breast cancer survivorsFebruary 19, 2018Breast CancerPatient & Survivor Care
Abemaciclib becomes first CDK inhibitor to clinch single-agent approval for breast cancerFebruary 19, 2018Breast Cancer
Hallmark tumor metabolism becomes a validated therapeutic targetDecember 10, 2017Breast CancerGastroenterologyGenitourinary CancerLeukemia, Myelodysplasia, TransplantationGastrointestinal Cancer